Memery Crystal advises medicinal cannabis investment vehicle Ananda Developments plc on NEX listing

Ananda’s strategy is focused on companies, projects and products requiring funding to further progress research and development, as well as companies developing or which have already developed, products that contain cannabis derived cannabinoids for commercialisation. Ananda Developments will seek to identify investment opportunities in companies and projects based in Israel, together with Canada and the Netherlands.

The Memery Crystal team consisted of partner Nick Davis and Director Mark O’Donnell

Nick Davis, CEO of Memery Crystal, who led the process commented:

“We are delighted to have advised Ananda on its admission to NEX. Given the importance of cannabis within the medical and therapeutic sectors, and the limited exposure investors currently have to companies like Ananda Developments, this NEX listing signifies an important development for the medicinal cannabis industry in the UK.

“It also comes at a time when a number of important conversations are taking place across the sector and the UK government is reviewing laws on the use of medicinal cannabis, as the potential benefits of medicinal cannabis continue to be explored across the globe.”

For further information

Memery Crystal

Victoria Savory

Tel: +44 (0)20 7242 5905

Celicourt Communications

Mark Antelme / Jimmy Lea

Tel: +44 (0) 207 520 9266

Notes to editors

Memery Crystal is an independent law firm providing high-quality advice to businesses and individuals. We are recognised leaders in key industry sectors, including technology, financial services, natural resources, retail and sport.

We have an in-depth knowledge of the legal and commercial issues within each of our sectors, as well as years of experience working with the full range of industry players, providing us with a strategic advantage in helping clients to achieve their specific goals.

Nick Davis recently appeared on Sky business news discussing with Ian King whether cannabis is a potential investment class in the UK listed company space.